Supply of Truseq compatible Duplex Y adaptors

The Royal Marsden NHS Foundation Trust, located in London, has completed a procurement process for the "Supply of Truseq compatible Duplex Y adaptors", a project crucial to their Molecular Diagnostic service where these DNA adaptors are used in high throughput sequencing experiments. The procurement process, designated as "direct" with a rationale based on a sole supplier due to patency, resulted in a contract awarded to Integrated DNA Technologies, a supplier based in London. The award has been active since 20th October 2025 and is set to continue until 20th October 2027, with an option for a 12-month extension.

The associated contract value is £674,440.37 net, with a gross amount of £809,328.44, underlining its significance in the laboratory reagents market category, specifically targeting pathology services. This tender presents a significant opportunity for businesses specialised in providing innovative laboratory reagents, particularly those involved in DNA sequencing technologies. As the requirements hinge on intellectual property rights due to the unique nature of the adaptors, primarily businesses with proprietary technologies would benefit.

While the primary contract has been awarded through direct procurement due to the niche market and patent protections, similar future procurement opportunities might emerge, offering collaborative or subcontracting possibilities. Businesses that can offer unique solutions or supplementary services could find potential growth opportunities by engaging with institutions like The Royal Marsden NHS Foundation Trust for their specialised needs.